drugset
drugset / Trial / NCT05895305

Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis

NCT05895305 ↗

Phase 0 Active not recruiting 45 enrolled Airiver Medical, Inc. Libra Medical · collab
NaSingle-groupOpen-labelTreatment

Summary

The goal of this Prospective Trial of Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Obstruction (OXYGEN-1) is to evaluate clinical safety and potential efficacy of the Airiver Pulmonary DCB in the treatment of benign central airway stenosis.

Timeline

Start
2023-05-16
Primary completion
2025-10-04
Completion
2029-10-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 3.5 ug/m2 —

Indications

tracheal stenosis